K231899 is an FDA 510(k) clearance for the HAtetracell™-C Titanium Cervical IBF System. Classified as Intervertebral Fusion Device With Bone Graft, Cervical (product code ODP), Class II - Special Controls.
Submitted by Innovasis, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on October 17, 2023 after a review of 111 days - within the typical 510(k) review window.
This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.
View all Innovasis, Inc. devices